OLGA FEDORENKO: Open Payments
NPI 1669855029 · COVENTRY, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,631 in 216 payments from 30 companies in 2025. Trend: 2023 $3,980 · 2024 $5,588 · 2025 $6,631
Food & beverage: $6,631
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $1,166 |
| ABBVIE INC. | 24 | $1,022 |
| PFIZER INC. | 22 | $601 |
| Lundbeck LLC | 20 | $591 |
| GlaxoSmithKline, LLC. | 13 | $325 |
| Axsome Therapeutics, Inc. | 10 | $285 |
| Abbott Laboratories | 5 | $257 |
| Amgen Inc. | 9 | $256 |
| Novo Nordisk Inc | 11 | $236 |
| Otsuka America Pharmaceutical, Inc. | 7 | $235 |
Products named: VRAYLAR, FARXIGA, VYEPTI, NURTEC ODT, AIRSUPRA, JARDIANCE, Auvelity, REXULTI.
Industry payments across RI — which companies pay providers there.
